Brainstorm Cell Therapeutics shares owned by Cypress Capital Management
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Cypress Capital Management
from 13F filings
Historical chart of Cypress Capital Management investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Cypress Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Cypress Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.7k | 10k | 0.27 |
| 2023-09-30 | $600 | 3.0k | 0.20 |
| 2023-06-30 | $2.1k | 1.0k | 2.06 |
| 2022-09-30 | $71k | 16k | 4.44 |
| 2022-06-30 | $3.0k | 1.0k | 3.00 |
| 2021-12-31 | $6.0k | 1.5k | 4.00 |
| 2021-06-30 | $4.0k | 1.0k | 4.00 |
| 2021-03-31 | $4.0k | 1.0k | 4.00 |
| 2020-12-31 | $5.0k | 1.0k | 5.00 |
| 2020-09-30 | $9.0k | 500 | 18.00 |
| 2020-06-30 | $6.0k | 500 | 12.00 |
More positions owned by Cypress Capital Management
View all positions for Cypress Capital Management